GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Clinical Transplantation, Wiley, Vol. 37, No. 3 ( 2023-03)
    Abstract: Donor‐derived cell free DNA (dd‐cfDNA) and gene expression profiling (GEP) offer noninvasive alternatives to rejection surveillance after heart transplantation; however, there is little evidence on the paired use of GEP and dd‐cfDNA for rejection surveillance. Methods A single center, retrospective analysis of adult heart transplant recipients. A GEP cohort, transplanted from January 1, 2015 through December 31, 2017 and eligible for rejection surveillance with GEP was compared to a paired testing cohort, transplanted July 1, 2018 through June 30, 2020, with surveillance from both dd‐cfDNA and GEP. The primary outcomes were survival and rejection‐free survival at 1 year post‐transplant. Results In total 159 patients were included, 95 in the GEP and 64 in the paired testing group. There were no differences in baseline characteristics, except for less use of induction in the paired testing group (65.6%) compared to the GEP group (98.9%), P   〈  .01. At 1‐year, there were no differences between the paired testing and GEP groups in survival (98.4% vs. 94.7%, P  = .23) or rejection‐free survival (81.3% vs. 73.7% P  = .28). Conclusions Compared to post‐transplant rejection surveillance with GEP alone, pairing dd‐cfDNA and GEP testing was associated with similar survival and rejection‐free survival at 1 year while requiring significantly fewer biopsies.
    Type of Medium: Online Resource
    ISSN: 0902-0063 , 1399-0012
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2739458-X
    detail.hit.zdb_id: 2004801-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    Online Resource
    Online Resource
    Ovid Technologies (Wolters Kluwer Health) ; 2019
    In:  Stroke Vol. 50, No. Suppl_1 ( 2019-02)
    In: Stroke, Ovid Technologies (Wolters Kluwer Health), Vol. 50, No. Suppl_1 ( 2019-02)
    Abstract: Introduction: The increased risk of ischemic stroke in black versus white U.S. residents is not fully explained by known risk factors. Influenza has been implicated as a stroke risk factor, and studies have shown that blacks less often receive influenza vaccination than whites. We investigated whether there is an increased black-white racial disparity in stroke incidence during flu season. Methods: We performed a retrospective cohort study using inpatient and outpatient claims between 2008-2015 from a nationally representative 5% sample of Medicare beneficiaries. We included patients of black or white race who were ≥66 years old. The outcomes were ischemic stroke outside of influenza season versus during influenza season, defined as December through March based on reports of peak influenza activity from the Centers for Disease Control and Prevention. We calculated incidence rates and used Cox regression models adjusted for demographics and vascular risk factors to examine the association between black race and ischemic stroke. Results: Among 1,511,393 white and 138,026 black beneficiaries, blacks were slightly younger (mean age, 72.7 vs 73.5), more often female (60.5% vs 56.9%), and less likely to have atrial fibrillation but more likely to have hypertension, diabetes, heart failure, and chronic kidney disease. During a 4.7 (±2.2) years of follow-up, 61,188 patients experienced a stroke. During influenza season, stroke incidence was 1.08 (95% CI, 1.02-1.11) per 100 person-years in blacks versus 0.72 (95% CI, 0.69-0.72) per 100 person-years in whites. Outside of influenza season, stroke incidence was 1.22 (95% CI, 1.19-1.26) per 100 person-years in blacks versus 0.80 per 100 person-years in whites (95% CI, 0.80-0.81). Blacks had a similarly increased hazard of stroke both during influenza season (HR, 1.58; 95% CI, 1.52-1.66) and outside of influenza season (HR, 1.58; 95% CI, 1.53-1.63). Conclusion: In a cohort of elderly U.S. patients, we found that the black-white disparity in stroke risk was not more pronounced during influenza season. Our findings do not support the hypothesis that influenza contributes to the black-white disparity in stroke risk.
    Type of Medium: Online Resource
    ISSN: 0039-2499 , 1524-4628
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2019
    detail.hit.zdb_id: 1467823-8
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 107, No. 7 ( 2023-07), p. 1624-1629
    Abstract: We investigated associations between primary graft dysfunction (PGD) and development of acute cellular rejection (ACR), de novo donor-specific antibodies (DSAs), and cardiac allograft vasculopathy (CAV) after heart transplantation (HT). Methods. A total of 381 consecutive adult HT patients from January 2015 to July 2020 at a single center were retrospectively analyzed. The primary outcome was incidence of treated ACR (International Society for Heart and Lung Transplantation grade 2R or 3R) and de novo DSA (mean fluorescence intensity 〉 500) within 1 y post-HT. Secondary outcomes included median gene expression profiling score and donor-derived cell-free DNA level within 1 y and incidence of cardiac allograft vasculopathy (CAV) within 3 y post-HT. Results. When adjusted for death as a competing risk, the estimated cumulative incidence of ACR (PGD 0.13 versus no PGD 0.21; P  = 0.28), median gene expression profiling score (30 [interquartile range, 25–32] versus 30 [interquartile range, 25–33] ; P  = 0.34), and median donor-derived cell-free DNA levels was similar in patients with and without PGD. After adjusting for death as a competing risk, estimated cumulative incidence of de novo DSA within 1 y post-HT in patients with PGD was similar to those without PGD (0.29 versus 0.26; P  = 0.10) with a similar DSA profile based on HLA loci. There was increased incidence of CAV in patients with PGD compared with patients without PGD (52.6% versus 24.8%; P  = 0.01) within the first 3 y post-HT. Conclusions. During the first year after HT, patients with PGD had a similar incidence of ACR and development of de novo DSA, but a higher incidence of CAV when compared with patients without PGD.
    Type of Medium: Online Resource
    ISSN: 0041-1337
    RVK:
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2023
    detail.hit.zdb_id: 2035395-9
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...